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Caco-2 cellsAbstract Objectives: The aim of this study was to determine the uptake mechanism of spinosin
(SPI) by the monocarboxylic acid transporters (MCTs) in Caco-2 cells. Methods: The Caco-2 cells
were pretreated with various monocarboxylic acids, and the uptake of spinosin from Caco-2 cells
was measured by High Performance Liquid Chromatography (HPLC). Key findings: Preloading
of various monocarboxylic acids enhanced the uptake of SPI, especially salicylic acid (a substrate
of MCTs) had a 23.4 times increase in SPI uptake, indicating that the monocarboxylic acid trans-
porters had an efflux effect on SPI uptake and salicylic acid had a strong inhibition on SPI efflux in
Caco-2 cells. At the same time, the uptake of SPI through Caco-2 cells was Na+- and temperature-
dependent, pretreatment without Na+ significantly increased the uptake of SPI by 1.85 times and
incubated at low temperature (4 C) SPI uptake increased 20% than that of 37 C. Furthermore,
SPI was transported mainly via a carrier-mediated transport: [Vmax = 5.364 lg/mg protein,
Km= 657.0 lg/mL]. Conclusion: The uptake of spinosin (SPI) in Caco-2 cells was mainly regulated
by the monocarboxylic acid transporters along with Salicylic acid.
 2016 The Authors. Production and Hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Spinosin (200-b-O-glucopyranosyl swertisin, C28H38O15), a C-
glycoside flavonoid, is one of the major flavonoids of semen
Zizhiphi spinozae (Yuan et al., 1987; Kawashima et al.,1997) Previous studies showed that spinosin played an impor-
tant role in sedation and hypnosis (Li and Bi, 2006), and
exerted anxiolytic-like effects and its mechanism appeared to
be modulated by GABAA and 5-HT1A receptors (Liu et al.,
2015). Several pharmacokinetic investigations of spinosin
revealed that it had a wide brain regional tissue distribution,
particularly in corpus striatum and hippocampus (Zhang
et al., 2015). However, the absolute bioavailability of spinosin
in rat was only 2.2% (Li et al., 2008). It had demonstrated that
efflux pump P-glycoprotein (P-gp) affected the absorption of
spinosin by vivo microdialysis (Ma et al., 2012) and situ
perfusion method (Huang et al., 2014), which may be one of
the reasons of its low bioavailability. But remaining less
The transport mechanism of monocarboxylate transporter 287research about the intestinal absorption mechanisms of spino-
sin was studied.
Transporter-mediated disposition plays an important role
in pharmacokinetic changes of many drugs (Feng et al.,
2014). Monocarboxylate transporters involve proton depen-
dent monocarboxylate transporters (MCTs; SLC16A) con-
tained 14 members which were identified based on sequence
homology (Halestrap and Price, 1999) and sodium coupled
monocarboxylate transporters (SMCTs) which contain only
two members, SLC5A8 and SLC5A12 (Coady et al., 2004;
Gopal et al., 2004; Srinivas et al., 2005). MCT1 is strongly
expressed on the basolateral surface of enterocytes, whereas
members of the SLC5A8 are expressed primarily on the apical
surface (Iwanaga et al., 2006). Monocarboxylate transporters
have significant impact on the intestinal absorption of its
substrates including some short-fatty acids such as acetic acid,
L-lactic acid, butyric acid, salicylic acid, nicotinic acid, suc-
cinic acid, citric acid, propionic acid and methanoic acid,
and a-cyano-4-hydroxycinnamate (CHC) is a specific compet-
itive inhibitor of MCT1, MCT2, and MCT4 (Halestrap and
Wilson, 2012; Halestrap, 2013).
The human colon adenocarcinoma cell line Caco-2 cells
are widely used as a valuable transport model system for
the small intestinal epithelium when grown on dishes or per-
meable membranes (Hidalgo et al., 1989). Caco-2 cells express
five isoforms of MCTs: MCT1, MCT3, MCT4, MCT5, and
MCT6; particularly, MCT1 is most abundant (Hadjiagapiou
et al., 2000). Furthermore, Caco-2 cells are often used to test
whether a compound is transporter-mediated by MCTs when
cultured on dishes or permeable membranes (Martel et al.,
2006; Kimura et al., 2014; Kensuke et al., 2014). Shim had
reported that the uptake of some flavonoids of naringin,
naringenin, morin, silybin and quercetin was affected by
MCT1 in Caco-2 cells (Shim et al., 2007). As spinosin which
has a relatively low absolute bioavailability is a C-glycoside
flavonoid, the aim of the study was to investigate whether
the mechanism of SPI uptaked in Caco-2 cells was mediated
via MCTs.
2. Materials and methods
2.1. Materials
Caco-2 cells were obtained from Institute of Basic Medical
Cell Resource Center of Chinese Academy of Medical
Sciences. Spinosin and phlorizin were purchased from Si
Chuan Weikeqi Medical Technology Co., Ltd. (Chengdu,
China), purity P98%. Acetic acid, L-lactic acid, butyric acid,
salicylic acid, nicotinic acid, succinic acid, citric acid, propi-
onic acid, methanoic acid, a-cyano-4-hydroxycinnamate
(CHC) and NaN3 were obtained from Dengke Chemical
Industries, Ltd. (Tianjin, China), purity P98%. Thymidine,
inosine, and uracil were purchased from Solarbio Science &
Technology, Ltd. (Beijing, China), purity P98%. Dulbecco’s
Modified Eagle’s Medium F-12 (DMEM F-12) and fetal
bovine serum (FBS) were purchased from Hyclone Life Tech-
nologies (Beijing, China). Acetonitrile of HPLC grade was
from Tedia Company, Inc. (Fairfield, OH, USA). Dimethyl
sulfoxide (DMSO) was purchased from MP Biomedicals,
LLC (Illkirch, France). The highest grade reagents were
purchased in this experiment.2.2. Cell culture
The Caco-2 cells were grown in the 100  20 mm culture dishes
at 37 C in a 5% CO2–95% air atmosphere between passages
35 and 45. The culture medium consisted of DMEM F-12,
10% FBS, 100 lg/mL streptomycin and 70 lg/mL penicillin
G. The confluent Caco-2 cells were cultured for 7–9 days for
uptake experiments, and the culture medium was fed with fresh
incubation medium three times every week.
2.3. Uptake experiments
Caco-2 cells were seeded in 100  20 mm culture dishes by
30  104 cell/mL for uptake experiments. HBSS balanced salt
solution (8 g/L NaCl, 0.4 g/L KCl, 0.14 g/L CaCl2, 0.06 g/L
MgSO47H2O, 0.06 g/L KH2PO4, 0.12 g/L mM Na2HPO4
12H2O), 1.0 g/L D-glucose, pH 5.0, 6.8, 7.0 or 7.4, and the
same concentration of KCl instead of Na+ was used as Na+
free HBSS balanced salt solution (pH 7.4). In time-, extracellu-
lar pH- and concentration-dependence on SPI uptake experi-
ments, cells were washed twice with 5.0 ml of HBSS
balanced salt solution (pH 7.4) then preincubated with 10 ml
of fresh HBSS for 20 min at 37 C to decrease interference.
After preincubation, the supernatant was removed, and
10 ml of HBSS containing different concentration of SPI was
added to each dish for certain times at 37 C. SPI and other
medications were dissolved in DMSO and the final concentra-
tion of DMSO in HBSS was lower than 1% for the uptake
experiments.
In effect of low temperature, metabolic inhibitor and
Na+-dependence on SPI uptake experiments, Caco-2 cells
were preincubated with 10 mM NaN3, Na
+ free or 4 C in
the incubation medium (pH 7.4) at 37 C or 4 C for 20 min
before incubating with SPI 10 min at the same temperature
with preincubation. To investigate the effect of various mono-
carboxylic acids and other transporters inhibitors on SPI
uptake, the cells were preincubated with 10 mM CHC, acetic
acid, L-lactic acid, butyric acid, salicylic acid, nicotinic acid,
succinic acid, citric acid, propionic acid, methanoic acid or
1 mM thymidine, inosine, uracil, 0.5 mM phlorizin (pH 7.4)
for 20 min at 37 C then incubated with SPI 10 min at the same
temperature with preincubation.
After treatment with SPI, the supernatant was removed,
and the cell surface was washed thirdly with 5 mL ice-cold
HBSS. Then 2.5 mL of solution (water/methanol = 1:1) was
added to each dish incubated for 60 min to extract SPI at room
temperature, then using a cell scraper the cells were scraped off
and collected in EP tubes. The suspension was centrifuged at
15,000g for 20 min, and a 30-lL aliquot of the supernatant
was injected into the High Performance Liquid Chromatogra-
phy (HPLC) system. The Bradford method was used to assay
the concentration of protein in each dish (Bradford, 1976).
2.4. Instrumentation and chromatographic conditions
The extract SPI was determined by an HPLC system with a
Waters 2695 pump and Waters 2489 UV detector, using an
EMPORE-2000 workstation for data acquisition. And a
XBP C18 (L) (5 lm, 4.6 mm  250 mm) analytical column
from Venusil Co. was used. The mobile phase was a binary
mixture of acetonitrile–water (20:80, v/v) and at a flow rate
Table 1 Effects of low temperature, Na+ and metabolic
inhibitor on the initial uptake of SPI in Caco-2 cells.
Compound Concentration
(mM)
n SPI uptake
(% of control)
Control 37 C 5 100 ± 2.95
4 C 5 120.11 ± 8.79*
Na+ free 5 285.52 ± 10.19*
NaN3(10 mM) 10 5 94.64 ± 5.95
Each point represents the mean ± SD for 5 determinations.
* P< 0.05 significantly different from the control.
288 X.L. Meng et al.of 1.0 mL/min, the wavelength of SPI detection was set at
335 nm, and all measurements were performed at room
temperature.
2.5. Statistical analyses
The parameters of the Michaelis–Menten equation to analyze
the saturation curve of SPI uptake, were performed by Graph-
Pad Prism 5.0.
The results are reported as the mean ± standard deviation
(SD), and were performed by one-way analysis of variance or
unpaired Student’s t-test, using the SPSS Statistics 17.0. The
results were considered significant if P< 0.05.
3. Results
3.1. Time-, extracellular pH- and concentration-dependence on
SPI uptake
When Caco-2 cells were incubated with SPI (80 lg/mL) up to
50 min at 37 C, there are no morphologic changes for 50 min
for the cells under microscope observation (4  10 magnifica-
tion). As shown in Fig. 1(a), the uptake of SPI that transported
into the cells decreased slowly, it reached a stable level at
10 min, and the 10-min incubation time was chosen to deter-
mine the uptake mechanism of the following studies. To inves-
tigate extracellular pH effect on SPI uptake, Caco-2 cells were
incubated with SPI (80 lg/mL) in Caco-2 cells at 10 min at
37 C at different pH of 5.0, 6.8, 7.0, and 7.4. As the extracel-
lular pH increased the content of SPI distinctly increased
(Fig. 1(b)), whereas the uptake of SPI at pH 7.4 had a 40%
reduction than that of pH 7.0, that indicating a pH-
stimulated on SPI uptake.
As shown in Fig. 1(c), concentration dependence of SPI
uptake was investigated at 37 C at pH 7.4. For kinetic studies,
the concentration of SPI in the medium up 10–400 lg/mL was
nonlinear, and the evaluated kinetic parameters Vmax and km
were 5.364 lg/mg protein and 657.0 lg/mL according to the
Michaelis–Menten equation. The results indicated that SPI
uptake was an unsaturable process and mainly via a
carrier-mediated transport at the range of 10–400 lg/mL in
Caco-2 cells.(a) (b
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Fig. 1 Time-, extracellular pH- and concentration-dependence on SP
cells. (b) Effect of extracellular pH on the uptake of SPI by Caco-2 Cells
(c) Concentration dependence of the uptake of SPI by Caco-2 cell
*P< 0.05 significantly different from the control.3.2. Effect of low temperature, metabolic inhibitor and
Na+-dependence on SPI uptake
To examine whether the uptake of SPI was related to temper-
ature, Na+ and energy expenditure, Caco-2 cells were incu-
bated with SPI 80 lg/mL for 10 min at low temperature
(4 C), or preincubated with NaN3 (a spiratory chain inhibitor)
or without Na+ free HBSS balanced salt solution (pH 7.4) for
20 min. The results (Table 1) showed that SPI uptake at low
temperature (4 C) increased 20% than that of 37 C, and
preincubation with NaN3 had no significant effect on SPI
uptake but decreased 6.4% lower than control. However,
pretreatment without Na+ significantly increased the uptake
of SPI by 1.85 times, suggesting that the uptake of SPI was
dependence of Na+ and temperature.
3.3. Effect of various monocarboxylic acids on SPI uptake
To determine whether the various monocarboxylic acids affect
SPI uptake, Caco-2 cells were preincubated with 10 mM
salicylic acid, CHC, L-lactic acid, butyric acid, nicotinic acid,
succinic acid, citric acid, methanoic acid, propionic acid and
acetic acid at 37 C for 20 min before incubated with SPI for
10 min at same temperature with preincubation. The results
(Table 2) showed that preincubating salicylic acid had a 23.4
times increase in SPI uptake, and CHC had a 4.3 times
increase in SPI uptake. Moreover, preincubated with some
short-chain fatty acids L-lactic acid, butyric acid, nicotinic
acid, succinic acid, citric acid, and methanoic acid also) (c) 
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were incubated in a medium at each pH containing SPI (80 lg/mL).
s. Each point represents the mean ± SE of 4–6 determinations.
Table 2 Effects of various compounds on the uptake of SPI in
Caco-2 cells.
Compound Concentration
(mM)
n SPI uptake
(% of control)
Control 10 5 100.1 ± 1.17
CHC 10 5 530.58 ± 18.19 *
Acetic acid 10 5 119.44 ± 6.91
L-Lactic acid 10 5 123.33 ± 3.74
*
Butyric acid 10 5 151.52 ± 5.64 *
Salicylic acid 10 5 2444.02 ± 38.31 *
Nicotinic acid 10 5 202.4 ± 12.61 *
Succinic acid 10 5 124.17 ± 4.84 *
Citric acid 10 5 250.95 ± 13.19 *
Propionic acid 10 5 120.35 ± 6.25
Methanoic acid 10 5 201.28 ± 8.42 *
Nucleosides
Thymidine 1 5 118.76 ± 19.43
Inosine 1 5 122.26 ± 7.11
Uracil 1 5 109.33 ± 0.55
SGLT2-inhibitor
Phlorizin 0.5 5 164.13 ± 4.3 *
Each point represents the mean ± SD for 5 determinations.
* P< 0.05 significantly different from the control.
The transport mechanism of monocarboxylate transporter 289profoundly increased SPI uptake by 23–150%. In contrast,
propionic acid and acetic acid had no significantly impact on
SPI uptake. These results suggested that monocarboxylic acid
transporters had an efflux effect on SPI uptake in Caco-2 cells.
3.4. Concentration dependence of CHC and salicylic acid on SPI
uptake
Concentration dependence of CHC and salicylic acid on SPI
uptake was investigated (Fig. 2(a)). During preincubation with
CHC and salicylic acid at the range of 0.1–10 mM at 37 C for
20 min, the uptake of SPI increased as the concentration of
CHC and salicylic acid increased. But salicylic acid was more
effective than CHC when increasing SPI uptake.
To identify whether SPI uptake in Caco-2 cells was trans-
ported by monocarboxylic transporter along with Salicylic
acid, cells were preloaded with or without 10 mM Salicylic acid
before incubation with SPI at the range of 40–160 lg/mL. As
shown in Fig. 2(b), a Lineweaver–Burk plot suggested that(a)
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Fig. 2 Concentration dependent of CHC and salicylic acid on SPI u
uptake by Caco-2 cells. (b) Lineweaver–Burk plots for the uptake of S
determinations.uptake of SPI was significantly stimulated by treatment with
salicylic acid, and the inhibition constant value (Ki) was
20.75 ± 5.38 lg/mL (mean ± SD) that indicated salicylic
acid had a strong inhibition on SPI efflux in Caco-2 cells.
4. Discussion
In our study, we investigated whether SPI was taken up by
monocarboxylate transporters in Caco-2 cells. The uptake of
SPI that transported into the Caco-2 cells decreased slowly,
and it reached a stable level at 10 min. Moreover, the SPI
uptake was Na+, temperature-dependent (Table 1) in Caco-2
cells, pretreatment without Na+ significantly increased the
uptake of SPI by 1.85 times and SPI uptake incubated at
low temperature (4 C) increased 20% than that of 37 C.
Preincubation with NaN3 (a spiratory chain inhibitor) had
no significant impact but decreased 6.4% lower than in control
cells. The concentration of SPI in the medium up to 10–400 lg/mL
was nonlinear, suggesting that SPI uptake was an unsaturable
process and mainly via a carrier-mediated transport in Caco-2
cells [Vmax = 5.364 lg/mg protein, km = 657.0 lg/mL]
according to the Michaelis–Menten equation. Preloading with
various monocarboxylic acids could increase the uptake of
SPI; especially, salicylic acid had a 23.4 times increase in SPI
uptake (Table 2), indicating that monocarboxylic acid trans-
porters had an efflux effect on SPI uptake. Furthermore, the
effect of salicylic acid on SPI uptake was concentration-
dependent and had a strong inhibition on SPI efflux in
Caco-2 cells. These results indicated that SPI was transported
by monocarboxylate transporters along with salicylic acid.
MCTs may be involved in the efflux or trans-stimulation
effect of certain drugs thereby playing an important role in
drug disposition (Vijay and Morris, 2014). For instance, the
restricted brain distribution of probenecid (Deguchi et al.,
1997) and 6-mercaptopurine (6-MP) (Deguchi et al., 2000)
was due to MCT mediated efflux from the brain. Moreover,
elangovan gopal HRPE cells were transfected with mouse
SMCT cDNA and in the presence of the inhibitor CHC,
uptakes of L-[14C] lactate and [14C] pyruvate increased
170 ± 7% and 165 ± 15% higher than in control cells. Acetyl-
salicylic acid inhibited uptake of a low concentration of
14C-butyrate while increasing uptake of a high concentration
in caco-2 cell (Gonc¸alves et al., 2009), and the uptake of telmis-
artan was enhanced by preloading of acetic acid (Goto et al.,(b) 
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290 X.L. Meng et al.2005). In this study, we found that monocarboxylic acid trans-
porters had an efflux effect on SPI uptake and salicylic acid
had a strong inhibition on SPI efflux in Caco-2 cells, which
may be an effective way to improve its pharmacodynamic
activity and intestinal absorption.
Nucleoside transporters (NTs) expressed in human gas-
trointestinal tract (Ritzel et al., 2001; Meier et al., 2007) are
important determinants for the transport of nucleoside-
derived drugs across cell membranes, and nucleosides such as
thymidine, inosine and uracil which are its substrates
(Damaraju et al., 2003; Jordheim and Dumontet, 2007;
Cano-Soldado et al., 2008). However preincubation with
thymidine, inosine, and uracil did not significantly affect SPI
uptake (Table 2), and these results suggested that SPI was
not taken up by NTs across Caco-2 cells. Sodium-dependent
glucose transporter 1 (SGLT1) is highly expressed on the brush
border membrane of the small intestine, and phloridzin is an
inhibitor of SGLT1 (Ikeda et al., 1989; Schulze et al., 2014).
Preincubation with phloridzin significantly increased the
uptake of SPI by 64% (Table 2) suggesting that SPI was taken
up partly via SGLT1 across Caco-2 cells. In summary, the
uptake of SPI was mainly transported by MCTs and partly
by SGLT1, but not mediated by NTs in Caco-2 cells.
5. Conclusion
The mechanism of spinosin uptake in Caco-2 cells was mainly
regulated by MCTs along with Salicylic acid, suggesting that
monocarboxylate transporters (MCTs) may directly affect
the therapeutic safety and efficacy of spinosin.
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